5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.26▼ | 4.26▼ | 4.26▼ | 4.32▼ | 4.95▼ |
MA10 | 4.28▼ | 4.33▼ | 4.36▼ | 4.37▼ | 4.81▼ |
MA20 | 4.41▼ | 4.45▼ | 4.45▼ | 4.91▼ | 4.22▼ |
MA50 | 4.68▼ | 4.89▼ | 4.96▼ | 4.65▼ | 4.13▼ |
MA100 | 5.13▼ | 5.38▼ | 5.27▼ | 4.36▼ | 31.56▼ |
MA200 | 5.39▼ | 4.99▼ | 4.63▼ | 4.11▼ | 494.96▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.011▼ | -0.003▼ | -0.001▼ | -0.093▼ | 0.241▲ |
RSI | 31.168▼ | 30.615▼ | 30.791▼ | 39.978▼ | 44.385▼ |
STOCH | 23.192 | 15.909▼ | 16.481▼ | 25.115 | 56.785 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -98.632▼ | -69.090 |
CCI | -133.829▼ | -129.488▼ | -132.481▼ | -117.282▼ | -21.096 |
Thursday, March 28, 2024 09:00 AM
Teekay Corp. provides international crude oil and other marine transportation services. Its lines of business include offshore production (FPSO units) and conventional tankers. The firm operates ...
|
Thursday, March 28, 2024 07:30 AM
March 28, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results ...
|
Thursday, March 28, 2024 05:01 AM
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
28/03/24 | 4.24 | 4.39 | 4.07 | 4.09 | 35,570 |
27/03/24 | 4.27 | 4.57 | 4.17 | 4.34 | 21,612 |
26/03/24 | 4.38 | 4.3804 | 4.2181 | 4.30 | 73,951 |
25/03/24 | 4.46 | 4.60 | 4.34 | 4.385 | 52,098 |
22/03/24 | 4.60 | 4.73 | 4.4001 | 4.46 | 22,666 |
21/03/24 | 4.39 | 4.67 | 4.39 | 4.58 | 69,117 |
20/03/24 | 4.14 | 4.44 | 4.14 | 4.39 | 40,692 |
19/03/24 | 4.395 | 4.395 | 4.22 | 4.24 | 40,542 |
18/03/24 | 4.64 | 4.6512 | 4.32 | 4.34 | 36,866 |
15/03/24 | 4.57 | 4.725 | 4.54 | 4.60 | 31,075 |
|
|
||||
|
|
||||
|
|